Coloplast A/S (CLPBY)
Makes medical devices for people managing bladder, bowel, and wound care issues.
$6.65+0.03%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-28.3%
The outlook
Coloplast trades near the lower end of its 52-week range, with analysts leaning bullish at an average buy rating and a price target roughly 25% above current levels. The stock shows mixed momentum relative to its moving averages, and carries a trailing P/E of 47.5, suggesting a premium valuation relative to current earnings.
What’s behind the score
Analyst consensusBuy — 2.5 avg of 4 analysts
Price trendMixed vs its moving averages
52-week range23% of the way from its 52-week low to high
Price targetAvg target +25% vs current price
Analyst price target
~12-month · 4 analysts$8.30average target+24.8% vs now
Now $6.65
Low $6.50High $12.20
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$14.99B
52-wk high
$10.03
52-wk low
$5.64
50-day avg
$6.09
200-day avg
$7.53
Trailing P/E
47.5